Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly J Larson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The American Surgeon|June 3, 2014
Associations between Charlson Comorbidity Index and surgical risk severity and the surgical outcomes in advanced-age patientsKelly J Larson, Ryan J Hamlin, Juraj Sprung, et al.
Paediatric Anaesthesia|May 7, 2015
Anesthesia and organic aciduria: is the use of lactated Ringer's solution absolutely contraindicated?Katerina Ruzkova, Toby N Weingarten, Kelly J Larson, et al.
Asia Pacific Allergy|February 6, 2015
Refractory intraoperative hypotension with elevated serum tryptaseJuraj Sprung, Kelly J Larson, Rohit D Divekar, et al.
Journal of Clinical Anesthesia|December 16, 2014
Myoclonus in patient on fluoxetine after receiving fentanyl and low-dose methylene blue during sentinel lymph node biopsyKelly J Larson, Erica D Wittwer, Wayne T Nicholson, et al.
Journal of Pathology Informatics|May 23, 2012
Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure modelsMarcin Klapczynski, Gerard D Gagne, Sherry J Morgan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 30, 2009
Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamsterAndrew J King, Jason A Segreti, Kelly J Larson, et al.
European Journal of Pharmacology|April 14, 2010
In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemiaAndrew J King, Jason A Segreti, Kelly J Larson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2009
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibitionPamela H Franklin, Patricia N Banfor, Paul Tapang, et al.
Journal of Medicinal Chemistry|January 24, 2012
Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1Vince S C Yeh, David W A Beno, Sevan Brodjian, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The American Surgeon|June 3, 2014
Associations between Charlson Comorbidity Index and surgical risk severity and the surgical outcomes in advanced-age patientsKelly J Larson, Ryan J Hamlin, Juraj Sprung, et al.
Paediatric Anaesthesia|May 7, 2015
Anesthesia and organic aciduria: is the use of lactated Ringer's solution absolutely contraindicated?Katerina Ruzkova, Toby N Weingarten, Kelly J Larson, et al.
Asia Pacific Allergy|February 6, 2015
Refractory intraoperative hypotension with elevated serum tryptaseJuraj Sprung, Kelly J Larson, Rohit D Divekar, et al.
Journal of Clinical Anesthesia|December 16, 2014
Myoclonus in patient on fluoxetine after receiving fentanyl and low-dose methylene blue during sentinel lymph node biopsyKelly J Larson, Erica D Wittwer, Wayne T Nicholson, et al.
Journal of Pathology Informatics|May 23, 2012
Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure modelsMarcin Klapczynski, Gerard D Gagne, Sherry J Morgan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 30, 2009
Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamsterAndrew J King, Jason A Segreti, Kelly J Larson, et al.
European Journal of Pharmacology|April 14, 2010
In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemiaAndrew J King, Jason A Segreti, Kelly J Larson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2009
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibitionPamela H Franklin, Patricia N Banfor, Paul Tapang, et al.
Journal of Medicinal Chemistry|January 24, 2012
Identification and preliminary characterization of a potent, safe, and orally efficacious inhibitor of acyl-CoA:diacylglycerol acyltransferase 1Vince S C Yeh, David W A Beno, Sevan Brodjian, et al.
Pageof 1